Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Select Medical Holdings (SEM) Income from Continuing Operations (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Income from Continuing Operations for 9 consecutive years, with 63775000.0 as the latest value for Q1 2026.

  • For Q1 2026, Income from Continuing Operations fell 14.66% year-over-year to 63775000.0; the TTM value through Mar 2026 reached 203576000.0, up 42.17%, while the annual FY2025 figure was 214533000.0, 65.04% up from the prior year.
  • Income from Continuing Operations hit 63775000.0 in Q1 2026 for Select Medical Holdings, up from 37742000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 76391000.0 in Q4 2023 and bottomed at 141769000.0 in Q4 2022.
  • Average Income from Continuing Operations over 5 years is 31606529.41, with a median of 41276000.0 recorded in 2024.
  • Year-over-year, Income from Continuing Operations crashed 313.8% in 2022 and then soared 568.35% in 2024.
  • Select Medical Holdings' Income from Continuing Operations stood at 141769000.0 in 2022, then soared by 153.88% to 76391000.0 in 2023, then crashed by 113.69% to 10456000.0 in 2024, then soared by 460.96% to 37742000.0 in 2025, then surged by 68.98% to 63775000.0 in 2026.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 63775000.0, 37742000.0, and 44180000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.